Understanding Biosimilar Insulin & the Role of Rapid Acting Insulin in Intensification

Introduction

In this lecture, Dr. Ahmed will outline basal insulin therapy for T2D patients highlighting on biosimilars while also discussing the differences between Premixes and Basal-Bolus in terms of flexibility and simplicity.

Objectives

1. Understanding why postprandial matters and why it's important to tackle postprandial hyperglycemia.
2. Distinguish insulin profile for premix insulin options and describe patient
characteristics, lifestyle options and patient capabilities suitable for each premixed insulin
options.
3. Understand the differences between Premixes and Basal-Bolus when is comes flexibility and simplicity.

This Course For :

Resident / Fellow ( Cardiology , Endocrinology & Metabolism , Family Medicine , Internal Medicine , Nephrology , General Practitioners )
Physician ( Cardiology , Endocrinology & Metabolism , Family Medicine , Internal Medicine , Nephrology , General Practitioners )

Speaker

Sponsored by :

Price

Course Fee

FREE

FREE
VAT Included
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 10 Nov 2021    To    17 Nov 2021
  • 08:30 PM  To  11:59 PM
  • Certificate Available
  • Online Recorded
  • 644
  Add to Calendar 11/10/2021 08:30 PM 11/17/2021 11:59 PM Asia/ Riyadh Understanding Biosimilar Insulin & the Role of Rapid Acting Insulin in Intensification Understanding Biosimilar Insulin & the Role of Rapid Acting Insulin in Intensification https://medicalacademy.org/portal/event/view/1610